QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Homology MedicinesInozyme PharmaESSA PharmaRigel PharmaceuticalsAkouos
SymbolNASDAQ:FIXXNASDAQ:INZYNASDAQ:EPIXNASDAQ:RIGLNASDAQ:AKUS
Price Information
Current Price$11.22$21.93$26.65$4.37$18.58
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.71.71.11.61.7
Analysis Score3.53.51.53.43.5
Community Score2.52.83.12.82.8
Dividend Score0.00.00.00.00.0
Ownership Score1.71.70.81.71.7
Earnings & Valuation Score0.60.60.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$30.43$36.00$24.50$8.33$33.00
% Upside from Price Target171.20% upside64.16% upside-8.07% downside90.69% upside77.61% upside
Trade Information
Market Cap$507.86 million$512.57 million$854.51 million$738.45 million$638.84 million
Beta-0.24N/A1.961.48N/A
Average Volume331,92468,164483,6444,194,268116,460
Sales & Book Value
Annual Revenue$1.67 millionN/AN/A$59.29 millionN/A
Price / Sales304.11N/AN/A12.45N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.73 per shareN/A$2.47 per share$0.32 per shareN/A
Price / Book1.96N/AN/A13.66N/A
Profitability
Net Income$-103,920,000.00N/A$-23,440,000.00$-66,890,000.00N/A
EPS($2.47)N/A($1.04)($0.40)N/A
Trailing P/E RatioN/A0.00N/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-5,386.00%N/AN/A-26.25%N/A
Return on Equity (ROE)-57.92%N/A-46.31%-44.96%N/A
Return on Assets (ROA)-45.33%N/A-45.08%-20.08%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.39%N/A
Current Ratio10.55%16.71%66.75%2.92%37.39%
Quick Ratio10.55%16.71%66.75%2.86%37.39%
Ownership Information
Institutional Ownership Percentage75.20%69.77%63.37%82.04%88.70%
Insider Ownership Percentage33.40%N/AN/A4.72%N/A
Miscellaneous
Employees206242516354
Shares Outstanding45.26 million23.37 million32.06 million168.98 million34.38 million
Next Earnings Date3/11/2021 (Estimated)2/25/2021 (Estimated)5/6/2021 (Estimated)3/2/2021 (Confirmed)2/25/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.